These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 38212555)

  • 1. Clinical Efficacy and Safety of Colistin Sulfate in the Treatment of Carbapenem-Resistant Organism Infections in Patients with Hematological Diseases.
    Wu Y; Jiang S; Li D; Wu Y; Li Q; Wang X; Liu B; Bao H; Wu D; Hu X
    Infect Dis Ther; 2024 Jan; 13(1):141-154. PubMed ID: 38212555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of colistin sulfate in the treatment of infections caused by carbapenem-resistant organisms: a multicenter retrospective cohort study.
    Peng D; Zhang F; Chen Y; Zhao C; Niu J; Yang J; Li Z; Chen C; Qiu S; Zhang H; Qin B; Fang X; Guo S; Liu Y; Shao H
    J Thorac Dis; 2023 Apr; 15(4):1794-1804. PubMed ID: 37197520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and validation of a prognostic nomogram to predict 30-day all-cause mortality in patients with CRO infection treated with colistin sulfate.
    Li W; Liu Y; Xiao L; Cai X; Gao W; Xu D; Han S; He Y
    Front Pharmacol; 2024; 15():1409998. PubMed ID: 39101134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of polymyxin E sulfate in the treatment of critically ill patients with carbapenem-resistant organism infections.
    Lu X; Zhong C; Liu Y; Ye H; Qu J; Zong Z; Lv X
    Front Med (Lausanne); 2022; 9():1067548. PubMed ID: 36643845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination Regimens with Colistin Sulfate versus Colistin Sulfate Monotherapy in the Treatment of Infections Caused by Carbapenem-Resistant Gram-Negative Bacilli.
    Hao M; Yang Y; Guo Y; Wu S; Hu F; Qin X
    Antibiotics (Basel); 2022 Oct; 11(10):. PubMed ID: 36290098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical efficacy and nephrotoxicity of intravenous colistin sulfate in the treatment of carbapenem-resistant gram-negative bacterial infections: a retrospective cohort study.
    Jin J; Zhu J; Zhu Z; Kim WY; O'Rourke J; Lin Z; Chen M
    Ann Transl Med; 2022 Oct; 10(20):1137. PubMed ID: 36388829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Effectiveness and Safety of Colistin Sulphate in Treating Infections Caused by Carbapenem-Resistant Organisms and Analysis of Influencing Factors.
    Ma YC; Sun YQ; Wu X; Wang YJ; Yang XL; Gu JJ
    Infect Drug Resist; 2024; 17():3793-3804. PubMed ID: 39247753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical Analysis of Colistin Sulfate in the Treatment of Hematonosis Infected by Multidrug-Resistant Gram-Negative Bacteria].
    Wu YB; Jiang SS; Wu YX; Li DY; Li Q; Wang X; Liu B; Bao HY; Hu XH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Dec; 31(6):1878-1884. PubMed ID: 38071076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of Central Nervous System Infection Caused by Multidrug-Resistant
    Yang X; Guo C; Wu G; Zhao K; Xiang D; Xu D; Liu D; He Y
    Infect Drug Resist; 2023; 16():6029-6038. PubMed ID: 37719653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute kidney injury with intravenous colistin sulfate compared with polymyxin B in critically ill patients: A real-world, retrospective cohort study.
    Yang QJ; Xiang BX; Song MH; Yang CY; Liang JH; Xie YL; Zuo XC
    Pharmacotherapy; 2024 Aug; 44(8):631-641. PubMed ID: 39046197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of sulbactam-durlobactam versus colistin for the treatment of patients with serious infections caused by Acinetobacter baumannii-calcoaceticus complex: a multicentre, randomised, active-controlled, phase 3, non-inferiority clinical trial (ATTACK).
    Kaye KS; Shorr AF; Wunderink RG; Du B; Poirier GE; Rana K; Miller A; Lewis D; O'Donnell J; Chen L; Reinhart H; Srinivasan S; Isaacs R; Altarac D
    Lancet Infect Dis; 2023 Sep; 23(9):1072-1084. PubMed ID: 37182534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of polymyxin B in carbapenem-resistant gram-negative organisms infections.
    Xia GL; Jiang RL
    BMC Infect Dis; 2021 Oct; 21(1):1034. PubMed ID: 34607561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical characteristics and prognostic risk factors analysis of carbapenem-resistant organism in the department of hematology].
    Chen SZ; Xu JJ; Xiao TT; Weng YX; Chen DB; Zhang Y; Ren JH; Luo XF; Zheng ZH; Zheng XY; Chen ZZ; Hu JD; Yang T
    Zhonghua Xue Ye Xue Za Zhi; 2021 Jul; 42(7):563-569. PubMed ID: 34455743
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparative study of polymyxin B and colistin sulfate in the treatment of severe comorbid patients infected with CR-GNB.
    Wang J; Shah BK; Zhao J; Xiong J; Wang C; Xie S
    BMC Infect Dis; 2023 May; 23(1):351. PubMed ID: 37231342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of polymyxins to treat carbapenem resistant infections in neonates and children.
    Thomas R; Velaphi S; Ellis S; Walker AS; Standing JF; Heath P; Sharland M; Dona' D
    Expert Opin Pharmacother; 2019 Mar; 20(4):415-422. PubMed ID: 30576264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population Pharmacokinetics of Colistin Sulfate in Critically Ill Patients: Exposure and Clinical Efficacy.
    Yu XB; Zhang XS; Wang YX; Wang YZ; Zhou HM; Xu FM; Yu JH; Zhang LW; Dai Y; Zhou ZY; Zhang CH; Lin GY; Pan JY
    Front Pharmacol; 2022; 13():915958. PubMed ID: 35784679
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparative effectiveness and mortality of colistin monotherapy versus colistin-fosfomycin combination therapy for the treatment of carbapenem-resistant Enterobacteriaceae (CRE) infections: A propensity score analysis.
    Katip W; Rayanakorn A; Oberdorfer P; Taruangsri P; Nampuan T; Okonogi S
    J Infect Public Health; 2024 May; 17(5):727-734. PubMed ID: 38513335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment outcome and adverse effects of colistin in adult patients with carbapenem-resistant gram-negative bacteremia from Pakistan.
    Babar ZU; Dodani SK; Nasim A
    Int J Infect Dis; 2021 May; 106():171-175. PubMed ID: 33705852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rectal culture could predict carbapenem-resistant organism bloodstream infection and reduce the mortality in haematological patients: A retrospective cohort study.
    Gao S; Yan R; Zhang S; Li L; Zhang R; Fan J; Qin J; Peng Y; Wan D; Cao W; Bian Z
    J Glob Antimicrob Resist; 2024 Mar; 36():96-104. PubMed ID: 38128727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical analysis of colistin sulfate in the treatment of pneumonia caused by carbapenem-resistant Gram-negative bacteria.
    Xu HC; Cui Y; Wang XY; Wu HB; Li W; Wang D; Lin N; Lin L; Zhang YH
    World J Clin Cases; 2024 May; 12(13):2173-2181. PubMed ID: 38808336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.